Los Angeles Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Los Angeles Capital Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55.5K	Hold	700	–	–	﹤0.01%	1487
2026 Q1	$52.6K	Hold	700	–	–	﹤0.01%	1486
2025 Q4	$51.9K	Buy	+700	New	+$52.7K	﹤0.01%	1586
2020 Q4	–	Sell	-5,421	Closed	-$257K	–	1527
2020 Q3	$257K	Sell	5,421 -16,799	-76%	-$933K	﹤0.01%	1316
2020 Q2	$1.31M	Sell	22,220 -54,008	-71%	-$3M	0.01%	751
2020 Q1	$3.6M	Buy	76,228 +20,252	+36%	+$1.13M	0.02%	396
2019 Q4	$3.38M	Buy	+55,976	New	+$3.34M	0.02%	512
2019 Q2	–	Sell	-10,341	Closed	-$839K	–	1382
2019 Q1	$839K	Sell	10,341 -15,360	-60%	-$991K	﹤0.01%	912
2018 Q4	$1.39M	Sell	25,701 -33,497	-57%	-$1.71M	0.01%	644
2018 Q3	$3.05M	Sell	59,198 -299,153	-83%	-$14.1M	0.02%	560
2018 Q2	$14.9M	Buy	358,351 +205,250	+134%	+$9.1M	0.08%	272
2018 Q1	$6.75M	Buy	153,101 +142,291	+1,316%	+$7.23M	0.04%	387
2017 Q4	$544K	Hold	10,810	–	–	﹤0.01%	1025
2017 Q3	$548K	Sell	10,810 -40,325	-79%	-$2.11M	﹤0.01%	991
2017 Q2	$2.6M	Buy	+51,135	New	+$2.38M	0.02%	549
2016 Q4	–	Sell	-807,729	Closed	-$29.6M	–	1198
2016 Q3	$29.6M	Sell	807,729 -38,935	-5%	-$1.22M	0.25%	122
2016 Q2	$19.7M	Buy	+846,664	New	+$27.3M	0.17%	163
2014 Q2	–	Sell	-7,115	Closed	-$307K	–	1248
2014 Q1	$307K	Buy	+7,115	New	+$345K	﹤0.01%	1053

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Los Angeles Capital Management's IONS Position: Q2 2026 in Review

Los Angeles Capital Management held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 700 shares worth $55.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1487.

Los Angeles Capital Management first reported a position in IONS in Q1 2014 and has held it in 18 quarters since. The position peaked at $29.6M in Q3 2016. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Los Angeles Capital Management held 700 shares of Ionis Pharmaceuticals worth $55.5K as of Q2 2026.
Los Angeles Capital Management left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
Ionis Pharmaceuticals made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1487 holding.
Los Angeles Capital Management first reported a position in Ionis Pharmaceuticals in Q1 2014 and has held it in 18 quarters since.
Los Angeles Capital Management's Ionis Pharmaceuticals position peaked at $29.6M in Q3 2016.
514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.